Skip Nav Destination

First Edition

Research Article August 14 2025

Molecular Determinants of Thrombosis Recurrence Risk Across Venous Thromboembolism Subtypes

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Supplementary data

Research Article August 14 2025

Epidemiology, Clinical Features, and Molecular Basis of TTMV::RARA-driven Acute Promyelocytic Leukemia

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Supplementary data

Research Article August 14 2025

Pooled CAR-T screening in nonhuman primates identifies designs with enhanced proliferation, trafficking, and persistence

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Supplementary data

Brief Report August 14 2025

Venetoclax plus gilteritinib is effective in preclinical models of FLT3-mutant BCL11B-a lineage-ambiguous leukemia

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Supplementary data

Research Article August 14 2025

Cryo-EM structure of the tissue factor/factor VIIa complex with a factor X mimetic reveals a novel allosteric mechanism

Josepha C Sedzro,Amanda L. Photenhauer,Fabienne Birkle,Katarina Meze,Alex Mortenson,Cade Duckworth,Po-Chao Wen,Sarah Kearns,Michael A. Cianfrocco,Emad Tajkhorshid,Melanie D. Ohi,James H. Morrissey

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Supplementary data

Research Article August 14 2025

Improved diagnostic screening and classification of clonal mast cell diseases by ultrasensitive KIT p.D816V detection

Paula Navarro-Navarro,María González-Tablas,Alba Pérez-Pons,Laura Sánchez-Muñoz,Ana Henriques,Iván Álvarez-Twose,Paula Nafria,David Araco-Sánchez,Cristina Morales-Cabeza,Horacio Caligaris,Lei Chen,David González-de-Olano,Óscar González-López,Luis Escribano Mora,Andrés C. García-Montero,María Jara-Acevedo,Alberto Orfao

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Supplementary data

Research Article August 11 2025

HPA-1a antibodies in FNAIT do not distinguish αvβ3 from αIIbβ3 and bind inactive integrins more strongly than active integrins

Janita Oosterhoff,Wendy Stam,Suze Rosanne van Brummelen,Arthur Bentlage,Thijs de Vos,Jose Maria de Pereda,Leendert Porcelijn,Rick Kapur,Masja De Haas,C Ellen van der Schoot,Gestur Vidarsson,Coert Margadant

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Supplementary data

Research Article August 11 2025

Risk factors and outcomes of asparaginase-associated pancreatitis in pediatric patients with ALL

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Supplementary data

Review Article August 4 2025

How I Manage Chronic Myeloid Leukemia During Pregnancy

Elisabetta Abruzzese,Ekaterina Chelysheva

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Research Article August 4 2025

Deciphering neutrophil dynamics in the focal lesion tumor microenvironment to overcome immunosuppression in multiple myeloma

Joshua Rivera,Qi Yan,Saeed Daneshmandi,Romain Lannes,Eriko Katsuta,Jee Eun Choi,Prashant K. Singh,Ahmed Belal,Ronald Alberico,Ian Lund,Magan Schaefer,Hamza Hassan,Sarah Parker,Kenneth C. Anderson,Nikhil C. Munshi,Mehmet K. Samur,Philip L. McCarthy,Jens Hillengass,Hemn Mohammadpour

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Supplementary data

Research Article August 1 2025

Disrupting tRNA modifications to target mitochondrial vulnerabilities in drug-resistant leukemia cells

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Supplementary data

Research Article August 1 2025

Metabolic Adaptation of Regenerative Hematopoiesis Depends on Docking-Independent Mitochondrial Connexin-43

Abhishek K Singh,Angelo D'Alessandro,Ashley Wellendorf,Daniel Gonzalez-Nieto,Matthew Kofron,Monika Dzieciatkowska,Leo Mejia,Luis Barrio,Marie-Dominique Filippi,Jose A. Cancelas

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Supplementary data

Research Article August 1 2025

Pretransplant targeting of TNFRSF25 and CD25 stimulates recipient Tregs in target tissues, ameliorating GVHD post-HSCT

Duneia McManus,Sabrina N Copsel,Brent J Pfeiffer,Dietlinde Wolf,Henry Barreras,Symon Ma,Ali Khodor,Seitaro Komai,Marina Burgos da Silva,Hajar Hazime,Miguel Gallardo,Sarah Grace R Lime,Marcel R.M. van den Brink,Jung-Hyun Park,Maria T Abreu,Geoffrey R Hill,Victor L Perez,Robert B Levy

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Supplementary data

Research Article July 30 2025

Multiomics analysis reveals the genetic and epigenetic features of high-risk NK cell-type chronic active EBV infection

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Supplementary data

Research Article July 30 2025

Final analysis of the RESONATE-2 study: up to 10 years of follow-up of first-line ibrutinib treatment for CLL/SLL

Jan A. Burger,Paul M. Barr,Tadeusz Robak, Prof.,Carolyn Owen,Alessandra Tedeschi,Anita Sarma,Piers EM Patten,Sebastian Grosicki,Helen McCarthy, Dr,Fritz Offner,Edith Szafer Glusman,Cathy Zhou,Anita Szoke,Lynne Neumayr,James P. Dean,Paolo Ghia,Thomas Kipps

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Supplementary data

Research Article July 30 2025

Disease risk but not remission status determines transplant outcomes in AML: long-term outcomes of the ASAP trial

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Supplementary data

Research Article July 30 2025

XPO1 Drives Resistance to Eprenetapopt and Azacitidine and Can Be Targeted in TP53-Mutated Myeloid Malignancies

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Supplementary data

Review Article July 29 2025

A clinical guide to TP53 mutations in myeloid neoplasms

Samuel Urrutia,Terrence N Wong,Daniel C. Link

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Research Article July 25 2025

Donor-derived CD7 CAR T cells for pediatric and adult relapsed/refractory T-ALL/LBL: a phase 2 trial

Jing Pan,Liping Zhao,Yibing Zhang,Samuel Seery,Yue Tan,Biping Deng,Lingling Shan,Zhuojun Ling,Fan Wu,Quangang Wang,Xinjian Yu,Qinlong Zheng,Xiuwen Xu,Ying Yuan,Zhenglong Tian,Yanlei Zhang,Shuixiu Peng,Alex H. H. Chang,Xiaoming Feng

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Supplementary data

Research Article July 25 2025

HiJAKing the Hematopoietic System: A Low-Frequency JAK2V617F Clone Drives Myeloproliferative Neoplasm Pathology

Dennis M Bonal,Alissa Oakes,Anna Chorzalska,Makayla Pardo,Max Petersen,Michael Yeh Clarke,Seo-Ho Lee,Adam J Olszewski,Diana Olguta Treaba,John L Reagan,Mark S Dooner,John Morgan,Paul Bertone,Ting Zhao,Wentian Yang,Corey E. Ventetuolo,Gabriela S Hobbs,Joslyn Mills,Patrycja M. Dubielecka

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Supplementary data

Research Article July 23 2025

TCA cycle mode switch determines the fate of pirtobrutinib-tolerant persister cells in mantle cell lymphoma

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Supplementary data

Research Article July 23 2025

A BCMA-mRNA vaccine is a promising therapeutic for multiple myeloma

Debasmita Dutta,Jiye Liu,Kenneth Wen,Arghya Ray,Alessandro Salatino,Xiangdong Liu,Annamaria Gulla,Teru Hideshima,Yan Song,Kenneth C. Anderson

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Supplementary data

Research Article July 23 2025

α-Ketoglutarate promotes amino acid depletion and suppresses B-cell lymphoma growth and development

Carine Jaafar,Purushoth Ethiraj,Zhijun Qiu,An-Ping Lin,Pedro Simonis Seabra Martins Ferrari,Ricardo Aguiar

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Supplementary data

Research Article July 15 2025

Factor IXa and Factor X Influence Factor VIIIa Stability and Inactivation Mechanisms In Vitro and In Vivo

Johnathan J. Morris,Nicole A. Parsons,Amelia R. Wilhelm,Robert J Davidson,Lauren K. Olenick,Connor T. Watson,Andrew R. Vanden Heuvel,Lindsey A. George

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Supplementary data

Review Article July 15 2025

The Treatment of Marginal Zone Lymphoma

Juan Pablo Alderuccio,Ariela Noy

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Research Article July 15 2025

Real-world outcomes of patients with aggressive B-cell lymphoma treated with epcoritamab or glofitamab

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Supplementary data

Research Article July 10 2025

Boosting CAR T-Cell Efficacy by Blocking Proteasomal Degradation of Membrane Antigens

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Supplementary data

Research Article July 3 2025

Restoring p53 wild-type conformation in TP53-Y220C-mutant acute myeloid leukemia

Bing Z Carter,Po Yee Mak,Edward Ayoub,Xiaogang Wu,Baozhen Ke,Yuki Nishida,Andrew Futreal,Lauren B Ostermann,Andrea D Bedoy,Steffen Boettcher,Courtney D. DiNardo,Anna Puzio-Kuter,Masha V Poyurovsky,Arnold J. Levine,Michael Andreeff

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Supplementary data

Review Article May 15 2025

How I Evaluate and Treat Resistance and Relapse in CML

Simona Soverini,Fausto Castagnetti

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Review Article May 12 2025

How I approach hematopoietic stem cell transplantation for CML in a TKI world

Yves Chalandon,Federico Simonetta,Stavroula Masouridi-Levrat

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Review Article April 16 2025

How I individualize treatment for chronic-phase CML

Ariel Monet Leyte-Vidal,Neil P. Shah

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Review Article March 25 2025

How I treat chronic myeloid leukemia in children and adolescents

Jing Chen,Meinolf Suttorp,Nobuko Hijiya

View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

Page 3 of 3

First Edition

Molecular Determinants of Thrombosis Recurrence Risk Across Venous Thromboembolism Subtypes

Epidemiology, Clinical Features, and Molecular Basis of TTMV::RARA-driven Acute Promyelocytic Leukemia

Pooled CAR-T screening in nonhuman primates identifies designs with enhanced proliferation, trafficking, and persistence

Venetoclax plus gilteritinib is effective in preclinical models of FLT3-mutant BCL11B-a lineage-ambiguous leukemia

Cryo-EM structure of the tissue factor/factor VIIa complex with a factor X mimetic reveals a novel allosteric mechanism

Improved diagnostic screening and classification of clonal mast cell diseases by ultrasensitive KIT p.D816V detection

HPA-1a antibodies in FNAIT do not distinguish αvβ3 from αIIbβ3 and bind inactive integrins more strongly than active integrins

Risk factors and outcomes of asparaginase-associated pancreatitis in pediatric patients with ALL

How I Manage Chronic Myeloid Leukemia During Pregnancy

Deciphering neutrophil dynamics in the focal lesion tumor microenvironment to overcome immunosuppression in multiple myeloma

Disrupting tRNA modifications to target mitochondrial vulnerabilities in drug-resistant leukemia cells

Metabolic Adaptation of Regenerative Hematopoiesis Depends on Docking-Independent Mitochondrial Connexin-43

Pretransplant targeting of TNFRSF25 and CD25 stimulates recipient Tregs in target tissues, ameliorating GVHD post-HSCT

Multiomics analysis reveals the genetic and epigenetic features of high-risk NK cell-type chronic active EBV infection

Final analysis of the RESONATE-2 study: up to 10 years of follow-up of first-line ibrutinib treatment for CLL/SLL

Disease risk but not remission status determines transplant outcomes in AML: long-term outcomes of the ASAP trial

XPO1 Drives Resistance to Eprenetapopt and Azacitidine and Can Be Targeted in TP53-Mutated Myeloid Malignancies

A clinical guide to TP53 mutations in myeloid neoplasms

Donor-derived CD7 CAR T cells for pediatric and adult relapsed/refractory T-ALL/LBL: a phase 2 trial

HiJAKing the Hematopoietic System: A Low-Frequency JAK2V617F Clone Drives Myeloproliferative Neoplasm Pathology

TCA cycle mode switch determines the fate of pirtobrutinib-tolerant persister cells in mantle cell lymphoma

A BCMA-mRNA vaccine is a promising therapeutic for multiple myeloma

α-Ketoglutarate promotes amino acid depletion and suppresses B-cell lymphoma growth and development

Factor IXa and Factor X Influence Factor VIIIa Stability and Inactivation Mechanisms In Vitro and In Vivo

The Treatment of Marginal Zone Lymphoma

Real-world outcomes of patients with aggressive B-cell lymphoma treated with epcoritamab or glofitamab

Boosting CAR T-Cell Efficacy by Blocking Proteasomal Degradation of Membrane Antigens

Restoring p53 wild-type conformation in TP53-Y220C-mutant acute myeloid leukemia

How I Evaluate and Treat Resistance and Relapse in CML

How I approach hematopoietic stem cell transplantation for CML in a TKI world

How I individualize treatment for chronic-phase CML

How I treat chronic myeloid leukemia in children and adolescents

Email alerts

ASH Publications

American Society of Hematology

First Edition

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only